Journal
NEUROBIOLOGY OF AGING
Volume 28, Issue 6, Pages 824-830Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2006.05.001
Keywords
IDE; MCI; CDR; beta-amyloid
Categories
Funding
- NIA NIH HHS [AG14766, AG14239, AG13799] Funding Source: Medline
- NATIONAL INSTITUTE ON AGING [R01AG014766, R01AG013799, R03AG014239] Funding Source: NIH RePORTER
Ask authors/readers for more resources
In this study we report that the mem brane-bound, but not cytosolic insulin degrading enzyme (IDE) protein concentration and IDE activity are significantly decreased in the hippocampal formation of cases affected by mild cognitive impairment (MCI) which are at high risk to develop Alzheimer's disease (AD), relative to normal neurological controls. Membrane-bound IDE protein concentrations and activity in the hippocampal formation continued to decrease during the conversion from MCI to mild-severe AD. This selective decrease in hippocampal membrane-bound, but not cytosolic, IDE concentration and activity was tissue specific since no changes in either membrane-bound or cytosolic IDE were found in the occipital cortex of the same cases examined. Most interestingly, the decreased hippocampal membrane-bound IDE protein activity negatively correlated with brain beta-amyloid (A beta)X-42 content in MCI and in AD brain. The study tentatively suggests that interventions aimed at promoting membrane-bound IDE activities in the brain of MCI cases may help to prevent the onset and possibly the progression into AD through mechanisms involving the clearance of monomeric A beta from the brain. (c) 2006 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available